Drug class
Thienotriazolodiazepine hypnotic; benzodiazepine-site positive allosteric modulator
Mechanism of action
Binds to the benzodiazepine site on GABA-A receptors and enhances GABA-mediated inhibitory neurotransmission; GABA-A receptor subtypes containing α1 subunits are associated with its hypnotic effects.
General use cases
- Short-term treatment of severe or debilitating insomnia only where authorised; approved use and product status vary by jurisdiction
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
